Rona M Smith

Summary

Affiliation: Addenbrooke's Hospital
Country: UK

Publications

  1. doi request reprint Biological therapy for lupus nephritis-tribulations and trials
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB2 0QQ, UK
    Nat Rev Rheumatol 6:547-52. 2010
  2. pmc Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
    Federico Alberici
    Department of Medicine, University of Cambridge School of Clinical Medicine, Vasculitis and Lupus Service, Addenbrooke s Hospital, Cambridge, UK, Department of Clinical and Experimental Medicine, University of Parma, Italy and Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK Department of Medicine, University of Cambridge School of Clinical Medicine, Vasculitis and Lupus Service, Addenbrooke s Hospital, Cambridge, UK, Department of Clinical and Experimental Medicine, University of Parma, Italy and Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK Department of Medicine, University of Cambridge School of Clinical Medicine, Vasculitis and Lupus Service, Addenbrooke s Hospital, Cambridge, UK, Department of Clinical and Experimental Medicine, University of Parma, Italy and Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
    Rheumatology (Oxford) 54:1153-60. 2015
  3. doi request reprint Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
    Rona M Smith
    Addenbrooke s Hospital, Cambridge, UK
    Arthritis Rheum 64:3760-9. 2012
  4. pmc Progress in treatment of ANCA-associated vasculitis
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB20QQ, UK
    Arthritis Res Ther 14:210. 2012

Collaborators

Detail Information

Publications4

  1. doi request reprint Biological therapy for lupus nephritis-tribulations and trials
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB2 0QQ, UK
    Nat Rev Rheumatol 6:547-52. 2010
    ..The complexities of clinical trials in lupus nephritis have impeded the demonstration of the efficacy of new agents, but if these difficulties can be overcome, there is a real chance that outcomes in lupus nephritis will improve...
  2. pmc Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
    Federico Alberici
    Department of Medicine, University of Cambridge School of Clinical Medicine, Vasculitis and Lupus Service, Addenbrooke s Hospital, Cambridge, UK, Department of Clinical and Experimental Medicine, University of Parma, Italy and Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK Department of Medicine, University of Cambridge School of Clinical Medicine, Vasculitis and Lupus Service, Addenbrooke s Hospital, Cambridge, UK, Department of Clinical and Experimental Medicine, University of Parma, Italy and Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK Department of Medicine, University of Cambridge School of Clinical Medicine, Vasculitis and Lupus Service, Addenbrooke s Hospital, Cambridge, UK, Department of Clinical and Experimental Medicine, University of Parma, Italy and Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
    Rheumatology (Oxford) 54:1153-60. 2015
    ..The aim of this study was to explore the long-term outcomes of AAV patients treated with repeat-dose RTX maintenance therapy...
  3. doi request reprint Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
    Rona M Smith
    Addenbrooke s Hospital, Cambridge, UK
    Arthritis Rheum 64:3760-9. 2012
    ..However, further relapse is common, and maintenance strategies are required. The aim of this study was to reduce relapse rates using a fixed-interval rituximab re-treatment protocol...
  4. pmc Progress in treatment of ANCA-associated vasculitis
    Rona M Smith
    Department of Renal Medicine, Addenbrooke s Hospital, Hills Road, Cambridge CB20QQ, UK
    Arthritis Res Ther 14:210. 2012
    ..As rare diseases, treatment advances in vasculitis depend on international collaborative research networks both to establish an evidence base for newer agents and to develop recommendations for patient management...